Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Discretionary categories like luxury and big ticket home purchases performed disproportionately poorly as inflation remained sticky and interest rates remained high.

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...

The 49-year-old football star has proved he's still got it as he left little to the imagination in the jaw-dropping selection ...

Cardinal Health had $210 billion in pharmaceutical and specialty drugs sales in fiscal 2024, up 11% year-over-year, helped in large part by GLP-1 sales. In Q4, segment sales rose 13% to $55 billion, ...

The British winner of last Friday's eyewatering £83million Euromillions jackpot is yet to come forward and claim their prize ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

From changing your eating windows to adding more fibre to your diet, there are simple tweaks you can make to how and what you ...